ISM-MSBV- PARTIAL_RETIREMENT -03-03-2026

Summary by AI ^BETAClose X

Morgan Stanley B.V. has announced a partial cancellation affecting several of its outstanding issuances, with settlement dates set for March 5, 2026. The unwind amounts range from £30,000.00 to £1,000,000.00 across various ISINs, resulting in remaining outstanding amounts such as £50,000.00 for ISIN XS2877570346 and £7,949,000.00 for ISIN XS3242814369. These cancellations will reduce the total outstanding issuance amounts for the affected securities.

Disclaimer*

Morgan Stanley B.V.

03 March 2026

Morgan Stanley & Co. International plc

25 Cabot Square

Canary Wharf

London E14 4QA, England

March 3, 2026

Notice of Partial Cancellation

Dear Sir/Madam:

Please note that there has been a Partial Cancellation by the issuer for the following ISIN(s) / CUSIP(s):

ISIN(s)/CUSIP(s)	Issuer	Unwind Amount	Outstanding Amount*	Settlement Date
XS2877570346	MORGAN STANLEY B.V.	150,000.00	50,000.00	05-Mar-2026
XS3242814369	MORGAN STANLEY B.V.	500,000.00	7,949,000.00	05-Mar-2026
XS3279812344	MORGAN STANLEY B.V.	100,000.00	100,000.00	05-Mar-2026
XS3242734765	MORGAN STANLEY B.V.	1,000,000.00	3,993,000.00	05-Mar-2026
XS3242849159	MORGAN STANLEY B.V.	30,000.00	250,000.00	05-Mar-2026
XS3242848003	MORGAN STANLEY B.V.	30,000.00	250,000.00	05-Mar-2026
XS3242848938	MORGAN STANLEY B.V.	30,000.00	250,000.00	05-Mar-2026
XS3242848854	MORGAN STANLEY B.V.	30,000.00	250,000.00	05-Mar-2026
XS3243129270	MORGAN STANLEY B.V.	400,000.00	300,000.00	05-Mar-2026
XS3279835048	MORGAN STANLEY B.V.	100,000.00	100,000.00	05-Mar-2026
XS3242848698	MORGAN STANLEY B.V.	30,000.00	250,000.00	05-Mar-2026
XS3043265142	MORGAN STANLEY B.V.	100,000.00	1,840,000.00	05-Mar-2026
XS3211807014	MORGAN STANLEY B.V.	55,000.00	1,270,000.00	05-Mar-2026

*Outstanding Amount reflects the Outstanding Issuance Amount post notification event.

In case of any questions do not hesitate to contact us for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END